STOCK MARKET BSE NSE

Cities need to follow Dharavi model to fight COVID: Epidemiologist Dr Giridhara R Babu

Dr Giridhara R Babu tells that infection can be widespread in slum areas and that other cities need to prepare robust plans similar to containment efforts in Dharavi.

Published: 03rd August 2020 10:33 AM  |   Last Updated: 03rd August 2020 10:33 AM   |  A+A-

A view of deserted roads near Dharavi during the lockdown.

A view of deserted roads near Dharavi during the lockdown. (File Photo | PTI)

By Express News Service

Even though the COVID fatality rate is as low as 0.09%, epidemiologist Dr Giridhara R Babu tells Sumi Sukanya Dutta that infection can be widespread in slum areas and that other cities need to prepare robust plans similar to containment efforts in Dharavi.

Epidemiologically, what do the government serosurvey findings from Mumbai and Delhi, released recently which showed overall seropositivity of about 40% in Mumbai and 23% in Delhi, signify? 

To say that infectious disease is well contained, we need to be assured that a reasonable proportion of the population is immune (develop antibodies or other immune mechanisms against the disease-causing agent). 

This is generally regarding vaccines. However, given that infection can be widespread in slum areas, other cities need to prepare robust plans similar to containment efforts in Dharavi. 

Also, the infection fatality rate is low, ranging between 0.09% and 0.45% based on these surveys in India. However, all these estimates are subject to correction as wider and frequent surveys need to be done in India.

How far could these two cities be from herd immunity? Once the population in an area reaches this level-what significance does it have in the course of a pandemic?

A key determinant of herd immunity is R0 or R nought. When R0 is 2.5, the proportion of the susceptible population is given (1/ R0), which is 0.4, indicating that 40% of the people are still susceptible to get the infection. 

In terms of Covid-19, it is not clearly known what the effective proportion of the population that needs to develop antibodies. For example, New York has a seroprevalence of 22.7%, London has 17.5% compared to 23-40% in Delhi and Mumbai. 

Given the limited understanding of the disease, it is my personal opinion that herd immunity cannot be a recommended goal or method to review our progress against covid19. We have seen how few countries have faltered keeping herd immunity as a method to fight against the disease.

Things seem to be settling down for at least Mumbai, Delhi and even Chennai. Is it safe so say that the worst is over for these cities? 

I am cautiously optimistic about these cities. Overall, it is a good thing: what was done in Dharavi is a great success. However, there are still problems, and the evidence about the disease is fast evolving, and we are all learning on the go. 

Clearly, this is not a time to rejoice. There is some early evidence suggesting that even among those who have mild or no symptoms, the long-term sequelae in terms of myocardial inflammation or cardiovascular diseases. This needs to be evaluated in India.


Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

IPL_2020
flipboard facebook twitter whatsapp